Profile of brentuximab vedotin and its potential in the treatment of relapsed or refractory Hodgkin lymphoma

Autor:	Timothy M Illidge, Adam Gibb, Sam Mayes
Rok vydání:	2012
Předmět:	Oncology medicine.medical_specialty business.industry Internal medicine medicine Refractory Hodgkin Lymphoma General Medicine business Brentuximab vedotin medicine.drug
Zdroj:	Blood and Lymphatic Cancer: Targets and Therapy. :99
ISSN:	1179-9889
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ee8582f881b5bab98a011d342ce39251 https://doi.org/10.2147/blctt.s21989 Zobrazit plný text záznamu